Eagle Pharmaceuticals Inc. (EGRX) Sank After FDA Denied BENDEKA Request

Eagle Pharmaceuticals Inc. (EGRX) announced Monday morning that the FDA has denied its request for seven years of orphan drug exclusivity in the U.S. for BENDEKA.

from RTT - Before the Bell http://ift.tt/1PCXvd5
via IFTTT